Fosamprenavir plus ritonavir increases plasma ketoconazole and ritonavir exposure, while amprenavir exposure remains unchanged (Q35912667)
Jump to navigation
Jump to search
scientific article published on 21 May 2007
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Fosamprenavir plus ritonavir increases plasma ketoconazole and ritonavir exposure, while amprenavir exposure remains unchanged |
scientific article published on 21 May 2007 |
Statements
1 reference
Fosamprenavir plus ritonavir increases plasma ketoconazole and ritonavir exposure, while amprenavir exposure remains unchanged (English)
1 reference
Mary B Wire
1 reference
Charles H Ballow
1 reference
Julie Borland
1 reference
Mark J Shelton
1 reference
Yu Lou
1 reference
Geoffrey Yuen
1 reference
Jiang Lin
1 reference
Eric W Lewis
1 reference
21 May 2007
1 reference
1 reference
2982-2984
1 reference
Identifiers
1 reference
1 reference
1 reference